CMPX vs QRVO · $367.4M cap vs P/E 27, rev $3.68B
Compass Therapeutics Inc. (CMPX) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported CMPX revenue for 2025-09-30 was $0. Net income was -$14.3M. CMPX currently screens at market cap $367.4M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
CMPX currently screens at market cap $367.4M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the CMPX and QRVO stock pages for the full models.
Not investment advice.